Vitamin D in Behcet's Disease, a Brief Review of the Literature

Mehmet Melikoglu1, Mestan Sahin2, Meltem Alkan Melikoglu3

  • 1Ataturk University School of Medicine, Dermatology, Erzurum, Turkey.

Insights

This review examines serum vitamin D levels in Behcet

Area of Science:

  • Immunology
  • Rheumatology
  • Endocrinology

Background:

  • Behcet's disease is a chronic inflammatory vasculitis with unknown causes.
  • Vitamin D is linked to various autoimmune and inflammatory conditions.
  • Existing research on vitamin D in Behcet's disease falls into four main categories.

Purpose of the Study:

  • To review and evaluate existing literature on serum vitamin D levels in Behcet's disease.
  • To synthesize findings regarding vitamin D's role in Behcet's disease susceptibility, pathogenesis, clinical activity, and treatment.

Main Methods:

  • Comprehensive literature review of studies investigating serum vitamin D in Behcet's disease.
  • Categorization of studies based on their focus: patient vs. control levels, disease susceptibility/pathogenesis, clinical involvement/activity, and vitamin D replacement therapy.

Main Results:

  • Previous studies have explored serum vitamin D levels in Behcet's disease patients compared to controls.
  • Research has also examined vitamin D's association with disease susceptibility, pathogenesis, and clinical manifestations.
  • The impact of vitamin D supplementation on Behcet's disease has been a subject of investigation.

Conclusions:

  • A significant body of research exists on serum vitamin D in Behcet's disease.
  • Further evaluation of these studies is needed to understand vitamin D's precise role.
  • This review consolidates current knowledge on vitamin D and Behcet's disease.

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.3K
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
5.4K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
15
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
18
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
434